Former Accuri CEO to lead intravenous device start-up
This article was originally published in Clinica
Tangent Medical Technologies, a development-stage company focused on next-generation intravenous access systems, has appointed Jeffrey Williams as CEO and chairman. Mr Williams was formerly president and CEO of flow cytometry specialist Accuri Cytometers until the company was sold to Becton Dickinson in March (www.clinica.co.uk, 21 March 2011). Prior to that, he was head of molecular diagnostic company HandyLab. Mr Williams succeeds Hank Brown, who was a founding investor of Ann Arbor, Michigan-based Tangent and has been leading the company since it was founded in July 2009. Tangent's lead product is the NovaCath peripheral IV system with integrated stablisation and blood containment features; the company expects to begin generating revenue from sales of the product in 2012.